MARKER THERAPEUTICS, INC. Increase (Decrease) in Other Operating Liabilities
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Other Operating Liabilities of $710.50 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2015-04-15
EUR
| Period end | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|
| 2009-12-31 | 17.00K EUR 10-Q/A · filed 2012-09-12 |
USD
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 149 month | Increase (Decrease) in Other Operating Liabilities 152 month | Increase (Decrease) in Other Operating Liabilities 155 month | Increase (Decrease) in Other Operating Liabilities 158 month | Increase (Decrease) in Other Operating Liabilities 161 month | Increase (Decrease) in Other Operating Liabilities 164 month | Increase (Decrease) in Other Operating Liabilities 167 month | Increase (Decrease) in Other Operating Liabilities 170 month | Increase (Decrease) in Other Operating Liabilities 173 month | Increase (Decrease) in Other Operating Liabilities 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $710.50K 10-Q · filed 2014-08-18 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | $48.83K derived: sum of 3 quarters · filed 2015-04-15 | $76.37K 10-K/A · filed 2014-04-17 | $710.50K 10-Q/A · filed 2014-05-21 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $48.83K derived: sum of 2 quarters · filed 2014-11-19 | $76.37K 10-Q · filed 2014-11-19 | $126.39K derived: sum of 4 quarters · filed 2014-11-19 | $710.50K 10-Q · filed 2013-11-19 | |||||||||
| 2013-06-30 | $48.83K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-18 | $76.37K 10-Q · filed 2014-08-18 | $126.39K derived: sum of 3 quarters · filed 2014-08-18 | $170.93K derived: sum of 4 quarters · filed 2014-08-18 | $710.50K 10-Q · filed 2013-08-19 | |||||||||
| 2013-03-31 | $27.54K 10-Q/A · filed 2014-05-21 | $77.56K derived: sum of 2 quarters · filed 2014-05-21 | $122.10K derived: sum of 3 quarters · filed 2014-05-21 | $140.02K derived: sum of 4 quarters · filed 2014-05-21 | $661.66K 10-Q/A · filed 2013-08-19 | |||||||||
| 2012-12-31 | $50.03K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $94.56K derived: sum of 2 quarters · filed 2013-11-19 | $112.48K derived: sum of 3 quarters · filed 2013-11-19 | $156.25K 10-K/A · filed 2014-04-17 | $634.13K 10-K · filed 2013-05-15 | |||||||||
| 2012-09-30 | $44.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $62.46K derived: sum of 2 quarters · filed 2013-11-19 | $106.22K 10-Q · filed 2013-11-19 | $145.00K derived: sum of 4 quarters · filed 2013-11-19 | $584.10K 10-Q · filed 2012-11-19 | |||||||||
| 2012-06-30 | $17.92K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-19 | $61.68K 10-Q · filed 2013-08-19 | $100.47K derived: sum of 3 quarters · filed 2013-08-19 | $114.57K derived: sum of 4 quarters · filed 2013-08-19 | $539.57K 10-Q/A · filed 2012-09-12 | |||||||||
| 2012-03-31 | $43.76K 10-Q/A · filed 2013-08-19 | $82.55K derived: sum of 2 quarters · filed 2013-08-19 | $96.65K derived: sum of 3 quarters · filed 2013-08-19 | $127.28K derived: sum of 4 quarters · filed 2013-08-19 | $521.64K 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | $38.78K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $52.89K derived: sum of 2 quarters · filed 2013-05-15 | $83.51K derived: sum of 3 quarters · filed 2013-05-15 | $117.99K 10-K · filed 2013-05-15 | $477.88K 10-K · filed 2012-04-16 | |||||||||
| 2011-09-30 | $14.10K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $44.73K derived: sum of 2 quarters · filed 2012-11-19 | $79.21K 10-Q · filed 2012-11-19 | |||||||||||
| 2011-06-30 | $30.63K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | $65.10K 10-Q/A · filed 2012-09-12 | ||||||||||||
| 2011-03-31 | $34.48K 10-Q · filed 2012-05-21 | |||||||||||||
| 2010-12-31 | $96.08K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |